Email Page Print Page

Contact Us

BioDelivery Sciences International

Corporate Headquarters

801 Corporate Center Drive, Suite 210
Raleigh, NC 27607
Tel: 919 582 9050
Fax: 919 582 9051

 

 

Business Development

 

BDSI has numerous established partnerships worldwide and continues to look for other companies interested in novel products or drug delivery technologies.  We are currently looking for companies interested in the following:

 

  • Partner for commercialization of BEMA Buprenorphine/Naloxone (BNX) outside the U.S.
  • Partner for commercialization of Clonidine Topical Gel, both within and outside the U.S.

 

BDSI is also interested in opportunities to in-license late-stage or marketed products in the U.S. in the areas of CNS - particularly pain and addiction.

 

Business Development Contact

Al Medwar

801 Corporate Center Drive, Suite 210
Raleigh, NC 27607
Tel: 919 582 9050
Fax: 919 582 9051

To contact us, use the form below.

First Name:
Last Name:
Company:
Contact Number:
Email:
Message:
Enter Text Above:

Can't Read It?
Click Below

Get the latest details on our products and services.

Top News

BioDelivery Sciences Launches InReach Support Program for Those Affected by Opioid Dependence
Website and Mobile App Offer Comprehensive Array of Information and Resources to Support Patients and Their Families


BioDelivery Sciences Announces Completion of Randomization in Phase 3 Trial of Clonidine Topical Gel for the Treatment of Painful Diabetic Neuropathy
Top line data anticipated by end of first quarter 2015